Compare LIQT & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LIQT | PYPD |
|---|---|---|
| Founded | 2004 | 2008 |
| Country | Denmark | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.3M | 66.2M |
| IPO Year | N/A | 2020 |
| Metric | LIQT | PYPD |
|---|---|---|
| Price | $1.78 | $3.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $4.20 | ★ $12.00 |
| AVG Volume (30 Days) | 14.4K | ★ 89.7K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $16,788,295.00 | N/A |
| Revenue This Year | $34.09 | N/A |
| Revenue Next Year | $18.75 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 10.97 | N/A |
| 52 Week Low | $1.34 | $2.30 |
| 52 Week High | $3.35 | $4.07 |
| Indicator | LIQT | PYPD |
|---|---|---|
| Relative Strength Index (RSI) | 39.37 | 57.27 |
| Support Level | $1.81 | $3.92 |
| Resistance Level | $1.85 | $4.05 |
| Average True Range (ATR) | 0.09 | 0.13 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 7.67 | 61.43 |
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.